. Author manuscript; available in PMC: 2016 Sep 21.

Published in final edited form as: Hepatology. 2009 Dec;50(6):1827–1838. doi: 10.1002/hep.23229

Table 1.

Baseline Characteristics of the Study Population

Parameters	Control (n = 50)	NAFL (n = 25)	NASH (n = 50)
Sex (F/M)	40/10	10/15	35/15
White/African American/others	30/4/16	19/3/3	39/4/3
Mean age (years)	36.82 ± 0.45	48.2 ± 2.1^*	52.52 ± 0.35^*
BMI (kg/m²)	21.22 ± 0.09	35.2 ± 0.89^*	32.12 ± 0.31^*
Fasting glucose (mg/dL)	81.3 ± 3.1	107.6 ± 11.4^*	101.2 ± 4.6^*
AST (normal range, 0–50 U/L)	27.4 ± 0.25	46.7 ± 6.3^*	52.85 ± 1.42^*
ALT (normal range, 0–50 U/L)	24.86 ± 0.35	83.7 ± 15.2^*	76.04 ± 2.9^*
Alkaline phosphatase (U/L)	54.76 ± 0.8	87.3 ± 5.2^*	95.39 ± 1.86^*
Total bilirubin (mg/dL)	0.4	0.6	0.7
Albumin (g/dL)	4.2	4.3	4.2
Total cholesterol (mg/dL)	178.18 ± 1.52	213.7 ± 10.2	189.85 ± 1.86
HDL-cholesterol (mg/dL)	55.4 ± 0.54	55.5 ± 2.4	46.8 ± 0.71^*
LDL-cholesterol (mg/dL)	99.84 ± 1.33	121.1 ± 6.8	117.44 ± 1.51^*
Triglycerides (mg/dL)	85.88 ± 1.62	183.6 ± 11.9^*	143.15 ± 2.2^*
Diabetes (%)	0	28^*	31^*
Hypertension (%)	0	52^*	63^*
Dyslipidemia (%)	0	56^*	56^*

BMI, body mass index; NAFL, nonalcoholic fatty liver; NASH, nonalcoholic steatohepatitis.

Data are expressed as mean ± SEM.

P < 0.05 versus control (ANOVA).